sloning logo
Latest News
 






Sloning BioTechnology specializes in the production of highly genetically diverse and precise customized libraries. We offer high quality, innovative, tailored protein engineering solutions to our industrial and biopharmaceutical customers worldwide.

 

Management
Scientific Advisory Board
Investors
Biosafety & Biosecurity
Jobs
News & Press Releases
Events and Conferences
GT&C and Downloads

screening
antibody


News & Press Releases
Sloning TOP3 company in Bavaria

Sloning was nominated one of the TOP3 companies in Bavaria in category "Start-up"
www.unternehmerkonferenz.de
 
Sloning Further Strengthens its Intellectual Property with New US Patent
Puchheim, Germany – April 13, 2010 – Sloning, leading supplier of synthetic biology tools was awarded US Patent No, 7,695,906. Sloning’s enabling platform technology -  Slonomics® - allows researchers to increase the success rate of their screening for new and optimized therapeutic antibodies, proteins or industrial enzymes.
Read more...
 
Sloning closes growth financing round led by LBBW-Venture
Puchheim, September 2009 – Sloning BioTechnology GmbH, the worldwide leading supplier of combinatorial gene libraries, received additional investments from all of its institutional shareholders: HBM BioVentures, LBBW Venture, DEWB and KfW to finance the company’s ongoing commercial growth strategy in the field of protein engineering.
Read more...
 
Sloning BioTechnology and Henkel to Co-Operate in Enzyme Development
Puchheim/Düsseldorf, June 2009 – Multinational consumer chemicals company Henkel will use Sloning BioTechnology’s proprietary protein engineering platform in their Laundry and Home Care enzyme development.
Read more...
 
More...
 

Sloning BioTechnology GmbH, Zeppelinstrasse 4, 82178 Puchheim, Germany t: +49 (0)89 80 90 95 0 f: +49 (0)89 80 90 95 50
Privacy Policy | General Terms & Conditions